Hyperbaric oxygen treatment of superficial soft tissue lesions in children with oncologic disease

Eleonora Cesca1, Giacomo Garetto, Emanuela Frascella

  • 1Department of Pediatrics.

Pediatric Reports
|June 13, 2012
PubMed

Insights

Hyperbaric oxygen therapy (HOT) is a safe and effective supportive treatment for superficial soft tissue lesions in pediatric cancer patients. Most children treated with HOT experienced positive outcomes, demonstrating its potential in oncology care.

Area of Science:

  • Pediatric Oncology
  • Hyperbaric Medicine
  • Supportive Care

Background:

  • Superficial soft tissue lesions are a common complication in pediatric cancer patients.
  • Supportive therapies are crucial for managing treatment side effects and improving patient outcomes.

Purpose of the Study:

  • To evaluate the feasibility and effectiveness of hyperbaric oxygen therapy (HOT) as an adjunctive treatment for superficial soft tissue lesions in pediatric oncology.
  • To assess the safety and tolerability of HOT in this patient population.

Main Methods:

  • Retrospective analysis of medical records from 1996-2010.
  • Inclusion of 12 pediatric patients (median age 7 years) with oncological diseases treated with HOT.
  • Review of treatment outcomes, lesion response, compliance, and adverse events.

Main Results:

  • Ten out of 12 patients achieved a cure.
  • Effectiveness varied by lesion type; efficacy was less certain for patients with skin grafts and flaps at risk.
  • Compliance was nearly 100%, with only one interruption due to local skin metastases.
  • HOT was found to be safe and effective, even in immunocompromised or critically ill children.

Conclusions:

  • Hyperbaric oxygen therapy is a feasible, safe, and effective supportive treatment for superficial soft tissue lesions in pediatric cancer patients.
  • HOT demonstrates significant potential in improving outcomes for this vulnerable population.
  • Further research may be warranted to optimize HOT protocols for specific lesion types.